MarketWinch Launches US-Based Accelerator to Help European and Israeli Medical Device Startups Scale into the American Healthcare Market

New service package significantly reduces costs, accelerates market entry, and helps startups navigate the complexities of the US healthcare system.

MarketWinch has established a new commercial-operational accelerator in the United States, which is set to transform how European and Israeli medical device startups expand into the American healthcare market. By providing a fully integrated service package, MarketWinch helps startups reduce market entry costs by approximately 80%, mitigate risks, and gain seamless access to US healthcare institutions. In doing so, it removes many of the traditional barriers to entry.

Founded by Ron Melts, a seasoned entrepreneur with over a decade of experience in the US healthcare industry, MarketWinch is built on a deep understanding of the challenges international medical device companies face when scaling in that country. Melts previously led two successful medical device companies in the US, overseeing rapid market penetration and high-profile exits, including Equashield’s expansion to over 1,200 hospitals and an exit valued at $1.3 billion.

For many international medical device startups, entering the US market requires significant financial investment, an understanding of complex regulatory frameworks, and the ability to navigate logistical and cultural barriers. Selling into healthcare institutions can be particularly challenging due to differences in business models, compliance requirements, and procurement processes. Additionally, securing the right infrastructure—such as warehousing, logistics, and operational support—can be costly and time-consuming.

MarketWinch was founded to eliminate these pain points. The company offers international startups access to a modular, end-to-end solution that provides critical support for startups at every stage of their expansion. This includes customs clearance, an FDA-approved logistics center in Long Island for medical device storage under regulated conditions, transportation to medical centers, insurance services, legal and regulatory compliance, healthcare billing, and sales team management.

MarketWinch delivers three key advantages to European and Israeli entrepreneurs. Firstly, by leveraging economies of scale, MarketWinch lowers market entry expenses from an estimated $20,000 per month to just a few thousand dollars. Furthermore, the company’s established infrastructure allows startups to receive orders from US healthcare institutions nationwide, ensuring deliveries within 24 hours. Thirdly, MarketWinch’s experienced team helps companies avoid costly mistakes, fines, or legal penalties that can arise from regulatory missteps.

“Our accelerator is designed to help European and Israeli medical device startups overcome the barriers to entering and scaling in the US healthcare market,” said Melts. “By providing an all-encompassing operational launchpad, we enable startups to focus on innovation while we manage the complexities of logistics, compliance, and commercial operations. Whether a company needs full-scale support or specific services such as warehousing, legal consulting, or sales management, our modular approach ensures a tailored and cost-effective solution.”

“Having successfully led medical device companies through the challenges of US market expansion, I understand what it takes to achieve rapid growth while minimizing risks. MarketWinch gives international startups a fast-track route to the heart of the American healthcare system, bypassing the traditional learning curve and accelerating their path to success.”

Startups looking to expand into the US healthcare market can learn more at https://www.marketwinch.com.

Ron Melts, CEO and Founder MarketWinch

Credit: MarketWinch